Our proprietary discovery platform relies on our deep expertise in immunology and
chemistry, supported by strong computational biology and the ability to exploit
difficult targets through our advanced discovery engine.
The key pillars of our discovery and development engine are the following:
We believe that the drug candidates generated from this platform, if approved, will significantly improve
the treatment paradigms and outcomes for patients, by fundamentally modulating the immune responses
in a range of cancers and allergic inflammatory diseases.